Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases

Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases

US Patent 9044478 · Granted Jun 2, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti Tau SVQIVYKPV epitope single domain antibody2025
Treatment of myotonic dystrophy2025
Compounds, pharmaceutical composition and their use in treating neurodegenerativ2020
1,4-bis(3-aminopropyl)piperazine derivative and its use2020
1,4-bis(3-aminopropyl)piperazine derivative and its use2020
1,4-bis(3-aminopropyl)piperazine derivative and its use2020
Treatment of myotonic dystrophy2020
Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-b2020
Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-b2020
Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-b2020
Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-b2020
Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-b2020